September 11, 2023 — Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging ...
September 8, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...
September 8, 2023 — Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company dedicated to developing ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
September 8, 2023 — Patients of African ancestry with dilated cardiomyopathy (DCM) are less likely to have clinically ...
September 7, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration approval ...
September 7, 2023 —Jessica Faulkner, PhD, a physiologist whose research is focused on sex differences in cardiovascular ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
September 7, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, announced that ...
September 7, 2023 — Vektor Medical, developer of the only technology to accurately map arrhythmias using just 12-lead ...

September 6, 2023 — The Cardiovascular Research Foundation (CRF) has announced the TCT 2023 late-breaking clinical ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
September 6, 2023 — The diagnosed severity of aortic stenosis strongly correlates with clinical outcomes, new Kaiser ...
September 6, 2023 — Vektor Medical, developer of the only technology to accurately map arrhythmias using just 12-lead ...
September 6, 2023 — Magenta Medical, developer of the Elevate heart pump system, an FDA Designated Breakthrough Device ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
September 6, 2023 — GE HealthCare and Mass General Brigham have announced, as part of its initial collaboration, the co ...
September 5, 2023 — New long-term follow-up results from two Phase 3 studies evaluating CAMZYOS (mavacamten), a first-in ...
September 5, 2023 — GE HealthCare announced the launch of a handheld, wireless ultrasound imaging system designed for ...